This is a single arm, single centre, investigator initiated study to investigate the use of
FAZA-PET in combination with MRI. FAZA is an investigational radiotracer used in PET scans.
FAZA PET/MRI will be used to measure hypoxia in sarcoma tissues of 14 patients who plan to
undergo neoadjuvant radiation/chemotherapy treatment.
After the FAZA PET/MRI scan, patients will be followed up via telephone, 48 hours after the
scan, to see if there are any side effects due to FAZA. Patients may also be requested to
repeat the FAZA scan after their standard of care radiation treatment.